Sirolimus-based graft-versus-host disease prophylaxis protects against cytomegalovirus reactivation after allogeneic hematopoietic stem cell transplantation: a cohort analysis

Sirolimus-based immunosuppressive regimens in organ transplantation have been associated with a lower than expected incidence of cytomegalovirus (CMV) disease. Whether sirolimus has a similar effect on CMV reactivation after allogeneic hematopoietic stem cell transplantation (HSCT) is not known. We...

Full description

Saved in:
Bibliographic Details
Main Authors: Marty, Francisco M., Bryar, Julie, Browne, Sarah K., Schwarzberg, Talya, Ho, Vincent T., Bassett, Ingrid V., Koreth, John, Alyea, Edwin P., Soiffer, Robert J., Cutler, Corey S., Antin, Joseph H., Baden, Lindsey R.
Format: Artigo
Language:Inglês
Published: American Society of Hematology 2007
Subjects:
Clinical Trials and Observations
Online Access:https://ncbi.nlm.nih.gov/pmc/articles/PMC1924486/
https://ncbi.nlm.nih.gov/pubmed/17392502
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1182/blood-2007-01-069294
Tags: Add Tag
No Tags, Be the first to tag this record!

Similar Items